Literature DB >> 1892760

Flow cytometric DNA ploidy pattern in dysplastic mucosa, and in primary and metastatic carcinomas in patients with longstanding ulcerative colitis.

G I Meling1, O P Clausen, A Bergan, A Schjølberg, T O Rognum.   

Abstract

Eighty-nine fresh tissue samples from flat colonic mucosa, polypoid lesions, macroscopically evident carcinomas, and metastatic carcinomas from ten patients with longstanding ulcerative colitis (greater than or equal to 8 years duration) were analysed by DNA flow cytometry and light microscopy. Of a total of ten carcinomas found in six patients, six showed DNA aneuploidy. Three patients developed metastatic carcinomas, all with aneuploid cell populations with similar DNA indices as in the primary carcinoma. Furthermore, aneuploid cell populations with similar DNA indices often occurred, both in separate mucosa samples, as well as in mucosa and carcinoma samples, from the same patient. DNA aneuploidy was found in flat mucosa in five of the six patients with carcinoma, and in one of the four patients without carcinoma (P greater than 0.1). High grade dysplasia was found in only four of the six cases with carcinoma, indicating that high grade dysplasia is insufficient as marker for malignant development. DNA aneuploidy was found in 24% of the dysplastic mucosa samples, and in 18% of the non-dysplastic mucosa samples (n.s., both with regard to high and low grade dysplasia). Since abnormal DNA ploidy pattern was not confined to dysplastic epithelium only, DNA aneuploidy in flat mucosa may constitute an additional marker in the identification of patients at increased cancer risk who could benefit from a closer surveillance.

Entities:  

Mesh:

Year:  1991        PMID: 1892760      PMCID: PMC1977516          DOI: 10.1038/bjc.1991.302

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

1.  DNA aneuploidy in ulcerative colitis.

Authors:  D M Melville; J M Northover; J R Jass; N A Shepherd; J E Lennand-Jones
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

2.  Cancer of the colon: the influence of the no-touch isolation technic on survival rates.

Authors:  R B Turnbull; K Kyle; F R Watson; J Spratt
Journal:  Ann Surg       Date:  1967-09       Impact factor: 12.969

3.  Surveillance for colonic carcinoma in ulcerative colitis.

Authors:  E Rosenstock; R G Farmer; R Petras; M V Sivak; G B Rankin; B H Sullivan
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

4.  The influence of tumour cell DNA abnormalities on survival in colorectal cancer.

Authors:  N C Armitage; R A Robins; D F Evans; D R Turner; R W Baldwin; J D Hardcastle
Journal:  Br J Surg       Date:  1985-10       Impact factor: 6.939

5.  Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development?

Authors:  R Löfberg; B Tribukait; A Ost; O Broström; H Reichard
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

6.  Preservation of cytometric DNA distribution and epithelial marker expression after tumor progression of human large bowel carcinomas.

Authors:  T O Rognum; E Thorud; P Brandtzaeg
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

7.  Flow cytometric detection of aneuploidy in colorectal adenomas.

Authors:  H F van den Ingh; G Griffioen; C J Cornelisse
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

8.  Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia.

Authors:  D F Ransohoff; R H Riddell; B Levin
Journal:  Dis Colon Rectum       Date:  1985-06       Impact factor: 4.585

9.  DNA aneuploidy in ulcerative colitis.

Authors:  J B Fozard; P Quirke; M F Dixon; G R Giles; C C Bird
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

10.  Origin of multiple "primary" colon carcinomas. A retrospective flow cytometric study.

Authors:  D Schwartz; B F Banner; D L Roseman; J S Coon
Journal:  Cancer       Date:  1986-11-01       Impact factor: 6.860

View more
  7 in total

Review 1.  Biology of colorectal cancer in ulcerative colitis.

Authors:  B A Lashner; B D Shapiro
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

2.  Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis.

Authors:  E Burum-Auensen; P M Deangelis; A R Schjølberg; Jo Røislien; S N Andersen; O P F Clausen
Journal:  J Clin Pathol       Date:  2007-02-23       Impact factor: 3.411

3.  Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells.

Authors:  Wendy S Garrett; Shivesh Punit; Carey A Gallini; Monia Michaud; Dorothy Zhang; Kirsten S Sigrist; Graham M Lord; Jonathan N Glickman; Laurie H Glimcher
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

4.  DNA aneuploidy in a case of rectosigmoid adenocarcinoma complicated by ulcerative colitis.

Authors:  K Makiyama; M Tokunaga; M Itsuno; W Zea-Iriarte; K Hara; T Nakagoe
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

5.  Telomere shortening correlates to dysplasia but not to DNA aneuploidy in longstanding ulcerative colitis.

Authors:  Mariann Friis-Ottessen; Laila Bendix; Steen Kølvraa; Solveig Norheim-Andersen; Paula M De Angelis; Ole Petter F Clausen
Journal:  BMC Gastroenterol       Date:  2014-01-09       Impact factor: 3.067

6.  Reduced hTERT protein levels are associated with DNA aneuploidy in the colonic mucosa of patients suffering from longstanding ulcerative colitis.

Authors:  Mariann Friis-Ottessen; Paula M De Angelis; Aasa R Schjølberg; Solveig N Andersen; Ole Petter F Clausen
Journal:  Int J Mol Med       Date:  2014-03-20       Impact factor: 4.101

7.  TP53/p53 alterations and Aurora A expression in progressor and non-progressor colectomies from patients with longstanding ulcerative colitis.

Authors:  Mariann Friis-Ottessen; Espen Burum-Auensen; Aasa R Schjølberg; Per Olaf Ekstrøm; Solveig N Andersen; Ole Petter Clausen; Paula M De Angelis
Journal:  Int J Mol Med       Date:  2014-10-20       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.